Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

The Impact of Cytogenetic Clonality on Outcomes in Younger Acute Myeloid Leukemia Patients: Results on 1290 Patients Included in the EORTC/Gimema AML-10 and AML-12 Trials

Blood (2017) 130 (Supplement 1): 1385.

https://doi.org/10.1182/blood.V130.Suppl_1.1385.1385

Published: 2017

Journal Articles

Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Frederic Baron, MD PhD, Marian Stevens-Kroef, PhD, Giovanna Meloni, MD, Petra Muus, MD PhD, Jean-Pierre Marie, MD, Constantijn J.M. Halkes, MD PhD, Xavier Thomas, MD PhD, Radovan Vrhovac, MD PhD, Giorgina Specchia, MD, Francois Lefrere, Sr., MD, Simona Sica, Marco Mancini, MD, Adriano Venditti, MD, Anne Hagemeijer, MD, Joop H. Jansen, PhD, Sergio Amadori, MD, Theo de Witte, MD, Roelof Willemze, MD PhD, Stefan Suciu, PhD

Blood (2016) 128 (22): 2847.

https://doi.org/10.1182/blood.V128.22.2847.2847

Published: 2016

Journal Articles

Improved Overall Survival with Gemtuzumab Ozogamicin (GO) Compared with Best Supportive Care (BSC) in Elderly Patients with Untreated Acute Myeloid Leukemia (AML) Not Considered Fit for Intensive Chemotherapy: Final Results from the Randomized Phase III Study (AML-19) of the EORTC and Gimema Leukemia Groups

Blood (2014) 124 (21): 619.

https://doi.org/10.1182/blood.V124.21.619.619

Published: 2014

Journal Articles

Low-Dose Decitabine Vs Best Supportive Care In Older Patients With AML and Low Blast Counts: Results Of a Subgroup Analysis Of The Randomized Phase III Study 06011 Of The EORTC Leukemia Cooperative Group and German MDS Study Group

Heiko Becker, MD, Stefan Suciu, PhD, Björn Rüter, MD, Uwe Platzbecker, MD, PhD, Aristoteles Giagounidis, MD, Dominik Selleslag, MD, Boris Labar, MD, PhD, Ulrich Germing, MD, Helmut R. Salih, MD, Petra Muus, MD, PhD, Karl-Heinz Pflüger, MD, Anne Hagemeijer, MD, PhD, Hans-Eckart Schaefer, MD, Frédéric Baron, MD, PhD, Arnold Ganser, MD, Carlo Aul, MD, Theo de Witte, MD, Pierre W. Wijermans, MD, Michael Lübbert, MD

Blood (2013) 122 (21): 1452.

https://doi.org/10.1182/blood.V122.21.1452.1452

Published: 2013

Journal Articles

Translocation t(1;6)(p35.3;p25.2) Involves RCC1 and IRF4 and Is Not Restricted to Unmutated Chronic Lymphocytic Leukemia

Natalie Put, MD, Els Lierman, PhD, Iwona Wlodarska, PhD, Anne Hagemeijer, Peter Vandenberghe, MD, PhD, Lucienne Michaux, MD PhD

Blood (2012) 120 (21): 4584.

https://doi.org/10.1182/blood.V120.21.4584.4584

Published: 2012

Journal Articles

Decitabine (DAC) Vs. Best Supportive Care in Elderly Patients with Intermediate- and High-Risk MDS with or without Monosomal Karyotypes: Results of the EORTC-LG/German MDS-SG Randomized Phase III Trial 06011.

Blood (2012) 120 (21): 2804.

https://doi.org/10.1182/blood.V120.21.2804.2804

Published: 2012

Journal Articles

Outcome of Older AML Patients with Adverse Cytogenetics, Including Single or Multiple Monosomies, Treated with the DNA Hypomethylating Agent Decitabine

Michael Lübbert, Claudia Schmoor, Anne Hagemeijer, Björn Hackanson, Rainer Claus, Björn Rüter, Mathias Schmid, Ulrich Germing, MD, Andrea Kuendgen, Volker Rethwisch, Arnold Ganser, MD, Uwe Platzbecker, MD, Oliver Galm, Wolfram Brugger, Gerhard Heil, Pierre W. Wijermans, Konstanze Döhner, Hartmut Döhner

Blood (2011) 118 (21): 2609.

https://doi.org/10.1182/blood.V118.21.2609.2609

Published: 2011

Journal Articles

In Childhood B-Lineage Acute Lymphoblastic Leukemia (B-ALL) with Hyperdiploidy >50 Chromosomes, Patients with 58 to 66 Chromosomes Have 99% EFS At 6-Year Follow-up: Results of the EORTC CLG 58951 Trial

Blood (2011) 118 (21): 565.

https://doi.org/10.1182/blood.V118.21.565.565

Published: 2011

Journal Articles

Will a Peripheral Blood (PB) Sample Yield the Same Diagnostic and Prognostic Cytogenetic Data as the Concomitant Bone Marrow (BM) In Myelodysplasia? An International Study Comparing Cytogenetics and Interphase FISH Using Parallel PB and BM Samples

Athena M Cherry, Ph.D., Marilyn L. Slovak, PhD, Lynda J Campbell, MBBS, FRCPA, Kathy Chun, PhD, Virginie Eclache, Detlef Haase, Claudia Haferlach, MD, Anne Hagemeijer, MD, Barbara Hildebrandt, Anwar M. Iqbal, PhD, Suresh C. Jhanwar, PhD, Michelle Lebeau, Kazuma Ohyashiki, MD, PhD, Francesc Solé, PhD, Daniel L. Van Dyke, PhD, Gordon Dewald

Blood (2010) 116 (21): 2922.

https://doi.org/10.1182/blood.V116.21.2922.2922

Published: 2010

Journal Articles

Influence of Karyotype On Overall Survival in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Azacitidine or a Conventional Care Regimen.

Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Steven D. Gore, MD, Valeria Santini, MD, Pierre Fenaux, MD, PhD, Lewis R. Silverman, MD, Anne Hagemeijer, MD, Barry Skikne, MD, Eva Hellstrom-Lindberg, MD, PhD, John F. Seymour, MBBS, PhD, FRACP, CL Beach, PharmD, Jay Backstrom, MD, MPH, Indrasiri Fernando, PhD

Blood (2009) 114 (22): 1755.

https://doi.org/10.1182/blood.V114.22.1755.1755

Published: 2009

Journal Articles

Implementation of Standardized International Karyotype Scoring Practices Is Needed to Provide Uniform and Systematic Evaluation for Patients with Myelodysplastic Syndrome Using IPSS Criteria: An International Working Group on MDS Cytogenetics Study

Kathy Chun, PhD, Anne Hagemeijer, MD, Anwar Iqbal, PhD, Marilyn L. Slovak, PhD

Blood (2008) 112 (11): 2681.

https://doi.org/10.1182/blood.V112.11.2681.2681

Published: 2008

Journal Articles

Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Blood (2006) 109 (8): 3451–3461.

https://doi.org/10.1182/blood-2006-08-041012

Published: 2006

Includes: Supplemental data

Journal Articles

Presence of Unbalanced Chromosomal Translocations Independently Predicts for Treatment Failure, Short Treatment-Free (TFS) and Overall Survival (OS) in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Treated with Cladribine.

Eric W. Van Den Neste, MD, PhD, Valérie Robin, Julie Francart, Anne Hagemeijer, Michel Stul, Andre Delannoy, Anne Sonet, Sabrina Costantini, Augustin Ferrant, Véronique Deneys, Annie Robert, Lucienne Michaux

Blood (2006) 108 (11): 2325.

https://doi.org/10.1182/blood.V108.11.2325.2325

Published: 2006

Journal Articles

Multicolor Fluorescence In Situ Hybridization (M-FISH) in Highly Aggressive B-Cell Lymphomas with 8q24/MYC Involvement Revealed the Heterogeneity of 13q Abnormalities with Unexpected Partial Gains.

Violaine Havelange, Geneviève Ameye, Evelyne Callet-Bauchu, Nicole Dastugue, Carole Barin, Dominique Penther, Lucienne Michaux, Anne Hagemeijer, Miikka Vikkula, Hélène Antoine-Poirel

Blood (2006) 108 (11): 2068.

https://doi.org/10.1182/blood.V108.11.2068.2068

Published: 2006

Journal Articles

Involvement of the NOTCH1 and NOTCH2 Genes in B-Cell Lymphomagenesis.

Iwona Wlodarska, PhD, Kim De Keersmaecker, Jan Cools, PhD, Chris De Wolf-Peeters, MD,PhD, Andre Bosly, MD,PhD, Monique Delos, MD, Lucienne Michaux, MD,PhD, Peter Vandenberghe, MD,PhD, Anne Hagemeijer, MD,PhD, Peter Marynen, PhD

Blood (2006) 108 (11): 2072.

https://doi.org/10.1182/blood.V108.11.2072.2072

Published: 2006

Journal Articles

Characterization of 14 NUP214-ABL1 Fusions in T-Cell Acute Lymphoblastic Leukaemia (T-ALL) Exhibits a Genomic Heterogeneity.

Carlos Graux, Marina Lafage, Nicole Dastugue, Francine Mugneret, Roland Berger, Stéphanie Struski, Marie-José Gregoire, Nathalie Nadal, Eric Lippert, Marian Stevens-Kroef, Jan Cools, Anne Hagemeijer, Hélène A. Poirel

Blood (2006) 108 (11): 2075.

https://doi.org/10.1182/blood.V108.11.2075.2075

Published: 2006

Journal Articles

NOTCH1 Is Targeted by Ig Translocations in NHL.

Iwona Wlodarska, PhD, Chris De Wolf-Peeters, MD, PhD, Jan Cools, PhD, Francesca Minnei, MD, Andre Bosly, MD, PhD, Monique Delos, MD, Lucienne Michaux, MD, PhD, Peter Vandenberghe, MD, PhD, Anne Hagemeijer, MD, PhD, Peter Marynen, PhD

Blood (2005) 106 (11): 4339.

https://doi.org/10.1182/blood.V106.11.4339.4339

Published: 2005

Journal Articles

Cytogenetics of 125 Untreated Patients with Binet Stages B or C B-CLL. Preliminary Results of a Multicentric Study from the French Cooperative Study Group on CLL.

Florence Nguyen-Khac, MD, PhD, Nathalie Leporrier, MD, Isabelle Radford-Weiss, MD, Christine Lefebvre, MD, Christian Bastard, MD, PhD, Anne Hagemeijer, MD, PhD, Isabelle Tigaud, MD, Marc Debraekeleer, MD, Michel Lessard, MD, PhD, Frederic Davi, MD, PhD, Claude Lesty, PhD, Leporrier Michel, MD, Helene Merle-Beral, MD, PhD, Sophie D. Raynaud, MD, PhD, Laurent Sutton, MD

Blood (2005) 106 (11): 5003.

https://doi.org/10.1182/blood.V106.11.5003.5003

Published: 2005

Journal Articles

Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32)

Kim De Keersmaecker, Carlos Graux, Maria D. Odero, Nicole Mentens, Riet Somers, Johan Maertens, Iwona Wlodarska, Peter Vandenberghe, Anne Hagemeijer, Peter Marynen, Jan Cools

Blood (2005) 105 (12): 4849–4852.

https://doi.org/10.1182/blood-2004-12-4897

Published: 2005

Journal Articles

FOXP1, a Highly Expressed Gene in a Subset of DLBCL, Is Targeted by a Recurrent t(3;14)(p13;q32).

Iwona Wlodarska, PhD, Peter Vandenberghe, MD PhD, Peet Nooien, MD, Anne Hagemeijer, MD PhD, Peter Marynen, PhD, Chris De Wolf-Peeters, MD PhD

Blood (2004) 104 (11): 2891.

https://doi.org/10.1182/blood.V104.11.2891.2891

Published: 2004

NARROW

The Impact of Cytogenetic Clonality on Outcomes in Younger Acute Myeloid Leukemia Patients: Results on 1290 Patients Included in the EORTC/Gimema AML-10 and AML-12 Trials

Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Low-Dose Decitabine Vs Best Supportive Care In Older Patients With AML and Low Blast Counts: Results Of a Subgroup Analysis Of The Randomized Phase III Study 06011 Of The EORTC Leukemia Cooperative Group and German MDS Study Group

Translocation t(1;6)(p35.3;p25.2) Involves RCC1 and IRF4 and Is Not Restricted to Unmutated Chronic Lymphocytic Leukemia

Decitabine (DAC) Vs. Best Supportive Care in Elderly Patients with Intermediate- and High-Risk MDS with or without Monosomal Karyotypes: Results of the EORTC-LG/German MDS-SG Randomized Phase III Trial 06011.

Outcome of Older AML Patients with Adverse Cytogenetics, Including Single or Multiple Monosomies, Treated with the DNA Hypomethylating Agent Decitabine

In Childhood B-Lineage Acute Lymphoblastic Leukemia (B-ALL) with Hyperdiploidy >50 Chromosomes, Patients with 58 to 66 Chromosomes Have 99% EFS At 6-Year Follow-up: Results of the EORTC CLG 58951 Trial

Will a Peripheral Blood (PB) Sample Yield the Same Diagnostic and Prognostic Cytogenetic Data as the Concomitant Bone Marrow (BM) In Myelodysplasia? An International Study Comparing Cytogenetics and Interphase FISH Using Parallel PB and BM Samples

Influence of Karyotype On Overall Survival in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Azacitidine or a Conventional Care Regimen.

Implementation of Standardized International Karyotype Scoring Practices Is Needed to Provide Uniform and Systematic Evaluation for Patients with Myelodysplastic Syndrome Using IPSS Criteria: An International Working Group on MDS Cytogenetics Study

Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Presence of Unbalanced Chromosomal Translocations Independently Predicts for Treatment Failure, Short Treatment-Free (TFS) and Overall Survival (OS) in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Treated with Cladribine.

Multicolor Fluorescence In Situ Hybridization (M-FISH) in Highly Aggressive B-Cell Lymphomas with 8q24/MYC Involvement Revealed the Heterogeneity of 13q Abnormalities with Unexpected Partial Gains.

Involvement of the NOTCH1 and NOTCH2 Genes in B-Cell Lymphomagenesis.

Characterization of 14 NUP214-ABL1 Fusions in T-Cell Acute Lymphoblastic Leukaemia (T-ALL) Exhibits a Genomic Heterogeneity.

NOTCH1 Is Targeted by Ig Translocations in NHL.

Cytogenetics of 125 Untreated Patients with Binet Stages B or C B-CLL. Preliminary Results of a Multicentric Study from the French Cooperative Study Group on CLL.

Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32)

FOXP1, a Highly Expressed Gene in a Subset of DLBCL, Is Targeted by a Recurrent t(3;14)(p13;q32).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only